和铂医药-B(02142.HK)11月13日耗资270万港元回购20万股
HBM HOLDINGSHBM HOLDINGS(HK:02142) Ge Long Hui·2025-11-13 11:03

Core Viewpoint - Heptagon Pharmaceuticals-B (02142.HK) announced a share buyback of 200,000 shares at a cost of HKD 2.7 million on November 13 [1] Group 1 - The company executed a buyback program, indicating a commitment to returning value to shareholders [1] - The total expenditure for the buyback was HKD 2.7 million, reflecting the company's financial strategy [1] - The number of shares repurchased was 200,000, which may influence the stock's market performance [1]